BioNTech Priority Review Voucher: Why It Is Paying Scholar Rock $205M
BioNTech will pay Scholar Rock $205 million for an FDA priority review voucher, one of the highest prices yet. Here is what it buys and where it may be used.
Tag: BioNTech
Read More